Sprint - Nextel 2005 Annual Report Download - page 86

The following table provides information about the shares of common stock, Series 1, that may be issued upon
exercise of awards as of December 31, 2005.
Plan Category
Number of Securities
to be Issued
Upon Exercise of
Outstanding Options,
Warrants and Rights
(1)
Weighted-average
Exercise Price of
Outstanding Options,
Warrants and Rights
(1)
Number of Securities
Remaining Available for
Future Issuance Under
Equity Compensation Plans
(Excluding Securities
Reflected in Column (1)
Equity compensation plans approved by
shareholders Common stock, Series 1 .... 125,652,494(2) $ 27.30(3) 86,605,084(4)(5)(6)(7)
Equity compensation plans not approved by
shareholders Common stock, Series 1 .... 84,435,111(8) $ 21.20(9) 48,487,836(10)
Total ................................ 210,087,605 135,092,920
(1) In connection with the spin-off of our local telecommunications business, it is anticipated that options to
purchase shares of common stock, Series 1, held by an employee who becomes an employee of Embarq will
be replaced with new options to purchase shares of the common stock of Embarq, and that options to
purchase shares of common stock, Series 1, held by other current or former employees will be adjusted
(both the number of shares subject to the options and the exercise price) to maintain the aggregate intrinsic
value of the options (i.e., the difference, at the time of the spin-off, between the value of the stock underlying
the options and the aggregate exercise price of the options).
(2) Includes 75,856,542 options and 9,084,933 restricted stock units outstanding under the 1997 Program and
39,984,772 options outstanding under the MISOP. Also includes 3,885 shares of common stock, Series 1,
issuable under the 1997 Program as a result of the purchase of those shares by directors with fourth quarter
2005 fees and purchase rights to acquire 722,362 shares of common stock, Series 1, accrued at
December 31, 2005 under the ESPP. Under the ESPP, each eligible employee may purchase common stock,
Series 1, at quarterly intervals at a purchase price per share equal to 90% of the market value on the last
business day of the offering period.
(3) The weighted average exercise price does not take into account the shares of common stock, Series 1,
issuable upon vesting of restricted stock units issued under the 1997 Program. These restricted stock units
have no exercise price. The weighted average price also does not take into account the 3,885 shares of
common stock, Series 1, issuable as a result of the purchase of those shares by directors with fourth quarter
2005 fees; the purchase price of these shares was $23.455 for each share. The weighted average purchase
price also does not take into account the 722,362 shares of common stock, Series 1, issuable as a result of
the purchase rights accrued under the ESPP; the purchase price of these shares was $21.11 for each share.
(4) Of these shares, 61,049,969 shares of common stock, Series 1, were available under the 1997 Program.
Although it is not our intention to do so, all of the shares, plus any shares that become available due to
forfeiture of outstanding awards, could be issued in a form other than options, warrants, or rights.
(5) Includes 25,555,115 shares of common stock, Series 1, available for issuance under the ESPP after issuance
of the 722,362 shares purchased in the fourth quarter 2005 offering. See note 2 above.
(6) Under the 1997 Long-Term Stock Incentive Program, the number of shares increases on January 1 of each
year by 1.5% of the common stock, Series 1 and 2, outstanding on that date. No awards may be granted
after April 15, 2007.
(7) No new options may be granted under the MISOP and therefore this figure does not include any shares of
our common stock, Series 1, that may be issued under the MISOP. Most options outstanding under the
MISOP, however, grant the holder the right to receive additional options to purchase our common stock,
75